NDAINJECTIONINJECTABLE
Approved
Jul 1969
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3
Data completeness
2/8 — Basic
Drug data last refreshed 21h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ARISTOSPAN (triamcinolone hexacetonide) is a long-acting corticosteroid administered via injection for inflammatory and autoimmune conditions. It is a synthetic glucocorticoid designed to provide sustained therapeutic effect at the site of injection or systemically. The drug works by suppressing immune and inflammatory responses through glucocorticoid receptor binding.
LOE Approaching
With LOE approaching and limited linked job count, the brand team is likely lean and focused on lifecycle extension or managed decline strategies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (3)
Study of Cingal® and Triamcinolone Hexacetonide for the Relief of Knee Osteoarthritis Pain
Started Sep 2020
231 enrolled
Osteoarthritis, Knee
Study of Cingal for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide at 39 Weeks Follow up
Started Dec 2017
526 enrolled
Knee Osteoarthritis
Study of Cingal™ for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide
Started May 2017
576 enrolled
Knee Osteoarthritis
Career Relevance
ARISTOSPAN represents a mature, declining-revenue product with minimal active job openings and limited growth prospects. Career moves on this brand are typically transitional, suited for professionals managing LOE strategies, generic competition, or leveraging established market relationships.
Worked on ARISTOSPAN at Ethypharm? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.